CPIG
Chicago Partners Investment Group Portfolio holdings
AUM
$3.47B
1-Year Return
16.46%
This Quarter Return
+5.89%
1 Year Return
+16.46%
3 Year Return
+59.01%
5 Year Return
+97.48%
10 Year Return
+126.98%
AUM
$1.92B
AUM Growth
+$209M
(+12%)
Cap. Flow
+$98.7M
Cap. Flow
% of AUM
5.13%
Top 10 Holdings %
Top 10 Hldgs %
24.02%
Holding
725
New
61
Increased
321
Reduced
266
Closed
41
Top Buys
| 1 |
Vanguard Value ETF
VTV
|
$9.53M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
$9.43M |
| 3 |
Vanguard Growth ETF
VUG
|
$5.52M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
$5.25M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$4.19M |
Top Sells
| 1 |
Dimensional Short-Duration Fixed Income ETF
DFSD
|
$6.56M |
| 2 |
Vanguard Large-Cap ETF
VV
|
$5.12M |
| 3 |
NVIDIA
NVDA
|
$2.52M |
| 4 |
Enterprise Products Partners
EPD
|
$1.3M |
| 5 |
Tesla
TSLA
|
$1.22M |
Sector Composition
| 1 | Energy | 9.31% |
| 2 | Financials | 8.24% |
| 3 | Technology | 6.88% |
| 4 | Healthcare | 2.46% |
| 5 | Utilities | 2.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLCA
651
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $154K | 0.01% |
12,127
-250
| -2% | -$3.19K |
|
652
Cytek Biosciences
CTKB
$501M
| $152K | 0.01% |
17,028
+5,710
| +50% | +$51K |
|
653
Sibanye-Stillwater
SBSW
$5.75B
| $143K | 0.01% |
+20,924
| New | +$143K |
|
654
Huntington Bancshares
HBAN
$26B
| $141K | 0.01% |
+11,728
| New | +$141K |
|
655
KeyCorp
KEY
$21B
| $141K | 0.01% |
+11,813
| New | +$141K |
|
656
SCYNEXIS
SCYX
$35.3M
| $117K | 0.01% |
40,829
-15,272
| -27% | -$43.7K |
|
|
MFM
657
MFS Municipal Income Trust
MFM
$212M
| $105K | 0.01% |
19,875
-24,647
| -55% | -$130K |
|
|
EVN
658
Eaton Vance Municipal Income Trust
EVN
$415M
| $101K | 0.01% |
10,234
+123
| +1% | +$1.21K |
|
|
PACW
659
DELISTED
PacWest Bancorp
PACW
| $98.1K | 0.01% |
+10,867
| New | +$98.1K |
|
660
Iovance Biotherapeutics
IOVA
$778M
| $92.4K | ﹤0.01% |
12,871
| – | – |
|
661
The GEO Group
GEO
$2.97B
| $83K | ﹤0.01% |
11,445
-75,044
| -87% | -$544K |
|
662
Wave Life Sciences
WVE
$1.25B
| $82.2K | ﹤0.01% |
18,799
-9,369
| -33% | -$40.9K |
|
|
DSM
663
BNY Mellon Strategic Municipal Bond Fund
DSM
$281M
| $78K | ﹤0.01% |
13,853
-20,152
| -59% | -$113K |
|
664
Vor Biopharma
VOR
$246M
| $74.7K | ﹤0.01% |
25,065
-2,286
| -8% | -$6.81K |
|
665
Geron
GERN
$874M
| $68.2K | ﹤0.01% |
21,309
+9,262
| +77% | +$29.6K |
|
666
Uranium Energy
UEC
$4.91B
| $66.7K | ﹤0.01% |
18,957
+8,829
| +87% | +$31.1K |
|
667
Cytosorbents Corp
CTSO
$60.5M
| $66.2K | ﹤0.01% |
19,760
+9,262
| +88% | +$31K |
|
668
Alpha Tau Medical Warrant
DRTSW
$6.51M
| $62.4K | ﹤0.01% |
203,324
| – | – |
|
669
W&T Offshore
WTI
$270M
| $60.8K | ﹤0.01% |
15,436
-4,490
| -23% | -$17.7K |
|
|
CLYM
670
Climb Bio, Inc. Common Stock
CLYM
$155M
| $45.7K | ﹤0.01% |
16,570
-1,950
| -11% | -$5.38K |
|
671
The RealReal
REAL
$984M
| $44.2K | ﹤0.01% |
+17,319
| New | +$44.2K |
|
|
PTRA
672
DELISTED
Proterra Inc. Common Stock
PTRA
| $41.6K | ﹤0.01% |
23,380
-2,782
| -11% | -$4.95K |
|
|
CBIO
673
Crescent Biopharma, Inc. Common Stock
CBIO
$185M
| $31.8K | ﹤0.01% |
200
| – | – |
|
674
Barnes & Noble Education
BNED
$285M
| $28.6K | ﹤0.01% |
187
| – | – |
|
675
Lumen
LUMN
$5.04B
| $27.5K | ﹤0.01% |
15,354
-621
| -4% | -$1.11K |
|